2009 Archives
Simple blood test to detect breast cancer?
What a fabulous early New Year’s gift!
Yesterday Scottish scientists reported their initial finding that a sugar change in blood may signal the presence of breast cancer. This research could lead to a simple blood test to screen patients for the onset of breast cancer. Providing a blood sample would be much less intrusive and less costly than a biopsy.
A U.S. charity has supplied the scientists with funding to conduct additional research on this exciting preliminary discovery. The original article can be found at http://www.eveningtimes.co.uk/news/editor-s-picks-ignore/blood-test-could-hold-key-to-breast-cancer-1.995228. Let’s pray that the initial results will be confirmed in 2010. I, for one, would opt for a simple blood test any day over a biopsy, even a fine-aspiration biopsy.
On that note of optimism, have a blessed, safe and healthful New Year!
Jan
Could Exercise be a Fountain of Youth?
A new study has revealed, at a molecular level, why those who regularly exercise are healthier as they age. The active people had cells that, when viewed under a microscope, were younger than those of the inactive people who participated in the study. This finding may explain how exercise helps prevent degenerative diseases associated with aging, such as heart attacks, diabetes and cancer.
Even though I got cancer at 43 despite my regular running routine, I believe this study: exercise is vital to health and keeps people youthful. Perhaps I would not have endured my grueling treatments as well if I had not exercised regularly before cancer struck.
The article describing this research can be found at: http://www.webmd.com/fitness-exercise/news/20091201/molecular-proof-exercise-keeps-you-young?ecd=wnl_skin_120909
A blessed Thanksgiving
Thanksgiving is a time of year to reflect on our lives and count our blessings, one by one, as the hymn goes. I have just been advised to stop taking Arimidex, an anti-estrogen daily pill I have taken for over six years. My former oncologist counseled me to stay on this pill for life, but my new doctor believes there is no further benefit, and there are even risks, in taking it longer than needed. So I will be stopping it starting in the New Year.
Since I had a recurrence two years after I got off tamoxifen in 2001, I am a bit apprehensive about discontinuing my daily Arimidex. It’s like a security blanket, but with prickly side effects. My doctor said I could take Evista (raloxifene) for a further five years to ward off my anxiety. But the possibility of experiencing deep vein thrombosis, stroke or other nasties from this tamoxifen-like drug do not seem worth it. And like Arimidex, this drug has no generic equivalent. So it would further drain my bank account as well as my estrogen.
This Thanksgiving I’m resolved to throw my fears out the window, to be grateful to God that I no longer need any adjuvant drug. I believe I’ve done all I can do to reduce my risk of another recurrence by enduring a bilateral mastectomy, two aggressive courses of chemo and a year of Herceptin.
Perhaps being off Arimidex will be like pressing the “Pause” button on my post-menopausal symptoms. Maybe my hair will have a chance to thicken and my night sweats, hot flashes and joint pain will subside. Maybe I’ll even lose weight! What a wonderful blessing all that would be. But if I don’t recover any youthful traits, that’s okay, too. My heavenly Father knows best. And for that I am the most grateful as we wrap up 2009.
A joyous and blessed Thanksgiving to one and all!
Jan
New mammography screening guidelines
As a breast cancer survivor who found her cancer at 43,I couldn’t let another day go by without commenting on yesterday’s breast cancer screening recommendations from a panel of experts. In case you haven’t heard, the U.S. Preventive Services Task Force recommends that women under 50 of low or average risk scrap being routinely screened for breast cancer. Their rationale? The risk of false positives and unneeded radiation and biopsies outweighs the benefits of blanket screening. A cost-benefit analysis also played into this recommendation. This panel still suggests mammograms for women with a family history of breast cancer or who are otherwise at high risk. For more details check out http://www.healthcentral.com/breast-cancer/news-417459-98.html?ic=6006.
These latest guidelines are controversial. The American Cancer Society, the American College of Radiology and some other experts disagree with the findings. Still, insurance companies might well use this panel’s newest release as an excuse not to cover mammograms for women in their forties.
I’d be interested in your opinion. Please join in taking the survey I’ve created on this controversial subject by clicking on the following link: http://www.surveymonkey.com/s.aspx?sm=MT1uhaKNg50glsw0BibO_2bw_3d_3d. Once the results are in, I will share them with you.
Happy Thanksgiving to one and all!
Jan
Newly diagnosed with breast cancer?
Wonder where I have been during October, Breast-Cancer Awareness Month? Busy with book signings, Reach to Recovery training for the American Cancer Society, and my new job as church secretary. But I am still very much engaged in the cause.
Here’s some interesting information for those who are newly diagnosed with breast cancer or know someone who is:
1. For aid in decision-making about breast-cancer treatment, visit www.mytreatmentdecision.com.
2. An interesting study about surgical decisions was published recently in the Journal of the National Cancer Institute (www.cancerconsultants.com/surgical-decision-making-early-stage-breast-cancer). Regardless of race or ethnicity, more women with early-stage breast cancer who were active in their own decision-making chose mastectomy than those who made a “shared or surgeon-based decision,” even though mastectomies and lumpectomies have been shown to be equivalent. Women concerned about recurrence or the effects of radiation were more likely to opt for mastectomy than those who did not share those concerns. In contrast, women concerned about body image or their spouse’s opinion were more likely to undergo a lumpectomy than those who did not voice those concerns.
This finding rang true for me: when I first had breast cancer at 43, I was concerned about body image and chose lumpectomy. But when at 53 I was diagnosed with a recurrence in the same breast, body image went out the window, and I chose a bilateral mastectomy. After my second bout with cancer I wished I had chosen a mastectomy the first time to avoid the recurrence and radiation effects. God had His reasons, however (one of them being to tell my story), and I’m good with that.
Happy October!
Jan
Detecting regional cancer spread with less pain
As a newly diagnosed breast cancer survivor in early 1996 I had 14 lymph nodes removed from my armpit (axial dissection) to detect breast cancer spread (stage my tumor). All 14 were clean of cancer. After chemo was complete that same armpit was radiated, further increasing my risk of developing lymphedema. In 1997 I developed arm swelling that was diagnosed as lymphedema.
Sound primitive by today’s standards? You bet it was!
The sentinel lymph node (SLN) biopsy became the standard of care a year or two after my diagnosis as a much less invasive way to stage the cancer. To identify the SLN(s), the surgeon injects a radioactive blue dye near the tumor. The surgeon then uses a scanner to find the SLN(s) containing or stained with the radioactive dye. Once the SLN(s) are located, the surgeon makes a small incision in the skin overlying the SLN and removes the lymph node(s).
The SLN(s) is/are then checked for the presence of cancer cells by a pathologist (a doctor who identifies diseases by studying cells and tissue under a microscope). If cancer is found, the surgeon will usually remove more lymph nodes during the biopsy procedure or during a follow-up surgical procedure. SLN biopsy may be done on an outpatient basis or require a short stay in the hospital.
But every procedure involving cancer staging or treatment, it seems, comes with a cost. A most recent article on the topic published by Ivanhoe Broadcast News (www.healthscout.com/news/1/8022281/main.html?ic=6006) reports that patients experience excruciating pain when injected with the radioactive tracer as part of the SLN procedure.
Here’s the good news: Eugene Woltering, M.D., a professor at the Louisiana State University Health Sciences Center in New Orleans, recently developed an alternative radioactive blue dye for use in the SLN biopsy. A study found that this dye, which lights up hard-to-see lymph nodes likely to be cancerous, works equally as well as the older dye, but without the pain. Further, the new procedure exposes the patient to one-third less radiation than the current one.
Kudos to Dr. Woltering for another advance to ease the journey for breast cancer patients, just in time for October, breast-cancer awareness month.